BSTC BioSpecifics Technologies Corp

58.38
+1.99  (+4%)
Previous Close 56.39
Open 57.64
Price To Book 3.44
Market Cap 428,319,815
Shares 7,336,756
Volume 53,689
Short Ratio
Av. Daily Volume 51,093
Stock charts supplied by TradingView

NewsSee all news

  1. BioSpecifics Appoints Mike Sherman and Corey Fishman to Board of Directors

    WILIMINGTON, Del., April 9, 2020 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ:BSTC), a biopharmaceutical company that originated and continues to develop collagenase-based therapies with a first in class

  2. BioSpecifics Appoints Joseph Truitt as Interim Chief Executive Officer

    WILIMINGTON, Del., April 9, 2020 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ:BSTC), a biopharmaceutical company that originated and continues to develop collagenase-based therapies with a first-in-class

  3. BioSpecifics Reports Fourth Quarter and Full Year 2019 Financial and Operating Results

    WILIMINGTON, Del., March 16, 2020 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ:BSTC), a biopharmaceutical company that originated and continues to develop collagenase-based therapies with a first in class

  4. BioSpecifics Reports Third Quarter 2019 Financial and Operating Results

    LYNBROOK, N.Y., Nov. 8, 2019 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ:BSTC), a biopharmaceutical company that originated and continues to develop collagenase-based therapies with a first in class

  5. Jennifer Chao Appointed Chairperson of BioSpecifics Technologies Corp. Board of Directors

    LYNBROOK, N.Y., Oct. 23, 2019 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ:BSTC), a biopharmaceutical company that originated and continues to develop collagenase-based therapies with a first in

Drug Information

Drug catalyst information is displayed when you hover over / tap on the stage bar graph.

Phase 2 topline data released June 2016 - endpoints met
XIAFLEX
Human lipomas
PDUFA date July 6, 2020.
XIAFLEX (collagenase clostridium histolyticum) - RELEASE
Edematous fibrosclerotic panniculopathy (“cellulite”)
Phase 2b trial did not meet endpoint. Endo is currently performing a commercial assessment.
XIAFLEX
Adhesive Capsulitis (“Frozen Shoulder syndrome”)
Phase 1 data released March 2019.
XIAFLEX
Uterine fibroids

Latest News

  1. BioSpecifics Appoints Mike Sherman and Corey Fishman to Board of Directors

    WILIMINGTON, Del., April 9, 2020 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ:BSTC), a biopharmaceutical company that originated and continues to develop collagenase-based therapies with a first in class

  2. BioSpecifics Appoints Joseph Truitt as Interim Chief Executive Officer

    WILIMINGTON, Del., April 9, 2020 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ:BSTC), a biopharmaceutical company that originated and continues to develop collagenase-based therapies with a first-in-class

  3. BioSpecifics Reports Fourth Quarter and Full Year 2019 Financial and Operating Results

    WILIMINGTON, Del., March 16, 2020 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ:BSTC), a biopharmaceutical company that originated and continues to develop collagenase-based therapies with a first in class

  4. BioSpecifics Reports Third Quarter 2019 Financial and Operating Results

    LYNBROOK, N.Y., Nov. 8, 2019 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ:BSTC), a biopharmaceutical company that originated and continues to develop collagenase-based therapies with a first in class

  5. Jennifer Chao Appointed Chairperson of BioSpecifics Technologies Corp. Board of Directors

    LYNBROOK, N.Y., Oct. 23, 2019 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ:BSTC), a biopharmaceutical company that originated and continues to develop collagenase-based therapies with a first in

  6. BioSpecifics Technologies Corp. Names J. Kevin Buchi as Chief Executive Officer

    LYNBROOK, N.Y., Oct. 10, 2019 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ:BSTC), a biopharmaceutical company that originated and continues to develop collagenase-based therapies with a first in class